Jane Street
PYXS icon

Jane Street’s Pyxis Oncology PYXS Stock Holding History

Jane Street’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
73,700
+48,200
+189% +$92.2K ﹤0.01% 9890
2026
Q1 		$37.2K Buy
+25,500
New +$38.4K ﹤0.01% 11066

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's PYXS Position: Q2 2026 in Review

Jane Street reduced its Pyxis Oncology (PYXS) stake by 4.7% in Q2 2026, selling an estimated $27.5K and leaving 290,090 shares worth $873K. The position accounts for ﹤0.01% of the portfolio, ranked #6811.

Jane Street first reported a position in PYXS in Q1 2023 and has held it in 11 quarters since. The position peaked at $904K in Q4 2025. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Jane Street held 290,090 shares of Pyxis Oncology worth $873K as of Q2 2026.
  • Jane Street sold 14,369 Pyxis Oncology shares in Q2 2026, an estimated $27.5K.
  • Pyxis Oncology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6811 holding.
  • Jane Street first reported a position in Pyxis Oncology in Q1 2023 and has held it in 11 quarters since.
  • Jane Street's Pyxis Oncology position peaked at $904K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.